Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Subjects

Subjects :

Female
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
Hematinics therapeutic use
Myelodysplastic Syndromes drug therapy
Severity of Illness Index

Details

Language :

English

ISSN :

1528-0020

Volume :

122

Issue :

13

Database :

MEDLINE

Journal :

Blood

Publication Type :

Editorial & Opinion

Accession number :

24072851

Full Text :

https://doi.org/10.1182/blood-2013-07-512442